These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1850359)

  • 1. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes.
    Erikstein BK; Smeland EB; Blomhoff HK; Funderud S; Prydz K; Lesslauer W; Espevik T
    Eur J Immunol; 1991 Apr; 21(4):1033-7. PubMed ID: 1850359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.
    Ware CF; Crowe PD; Vanarsdale TL; Andrews JL; Grayson MH; Jerzy R; Smith CA; Goodwin RG
    J Immunol; 1991 Dec; 147(12):4229-38. PubMed ID: 1661312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway.
    Santis AG; Campanero MR; Alonso JL; Sánchez-Madrid F
    Eur J Immunol; 1992 Dec; 22(12):3155-60. PubMed ID: 1359970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
    Suzuki T; Cooper MD
    J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.
    Dett CA; Gatanaga M; Ininns EK; Cappuccini F; Yamamoto RS; Granger GA; Gatanaga T
    J Immunol; 1991 Mar; 146(5):1522-6. PubMed ID: 1847164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.
    Santis AG; Campanero MR; Alonso JL; Tugores A; Alonso MA; Yagüe E; Pivel JP; Sánchez-Madrid F
    Eur J Immunol; 1992 May; 22(5):1253-9. PubMed ID: 1577066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
    Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
    J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation.
    Gehr G; Gentz R; Brockhaus M; Loetscher H; Lesslauer W
    J Immunol; 1992 Aug; 149(3):911-7. PubMed ID: 1321854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation.
    Trefzer U; Brockhaus M; Lötscher H; Parlow F; Budnik A; Grewe M; Christoph H; Kapp A; Schöpf E; Luger TA
    J Clin Invest; 1993 Jul; 92(1):462-70. PubMed ID: 8392091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities.
    Medvedev AE; Sundan A; Espevik T
    Eur J Immunol; 1994 Nov; 24(11):2842-9. PubMed ID: 7957575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B; Gately M; Espevik T
    J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells.
    Winzen R; Wallach D; Engelmann H; Nophar Y; Brakebusch C; Kemper O; Resch K; Holtmann H
    J Immunol; 1992 Jun; 148(11):3454-60. PubMed ID: 1316917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
    Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells.
    Ware CF; Crowe PD; Grayson MH; Androlewicz MJ; Browning JL
    J Immunol; 1992 Dec; 149(12):3881-8. PubMed ID: 1281193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
    Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
    Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
    Bjorndahl JM; Sung SS; Hansen JA; Fu SM
    Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A member of the tetra spans transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. Cloning and preliminary functional studies.
    Gil ML; Vita N; Lebel-Binay S; Miloux B; Chalon P; Kaghad M; Marchiol-Fournigault C; Conjeaud H; Caput D; Ferrara P
    J Immunol; 1992 May; 148(9):2826-33. PubMed ID: 1573270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.
    Zuber CE; Galizzi JP; Vallé A; Harada N; Howard M; Banchereau J
    Eur J Immunol; 1990 Mar; 20(3):551-5. PubMed ID: 2318249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.